Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies specific for urokinase-type plasminogen activator and methods of use thereof for treating cancer

Antibodies specific for urokinase-type plasminogen activator and methods of use thereof for treating cancer

US Patent 10239954 · Granted Mar 26, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chemically controlled monoclonal antibody target engagement2025
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2025
Matriptase and u-plasminogen activator substrates and other cleavable moieties a2024
Techniques for analytical instrument performance diagnostics2023
Matrix metalloproteinase substrates and other cleavable moieties and methods of 2023
Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and 2023
Compounds binding to fibroblast activation protein alpha2023
Compositions and methods of diagnosing pancreatic cancer2023
Activatable membrane-interacting peptides and methods of use2023
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2023
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2023
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2022